Next Article in Journal
Modeling Calculation and Synthesis of Alumina Whiskers Based on the Vapor Deposition Process
Next Article in Special Issue
1T1R Nonvolatile Memory with Al/TiO2/Au and Sol-Gel-Processed Insulator for Barium Zirconate Nickelate Gate in Pentacene Thin Film Transistor
Previous Article in Journal
Dispersions of Goethite Nanorods in Aprotic Polar Solvents
Previous Article in Special Issue
Wet-Chemical Synthesis of 3D Stacked Thin Film Metal-Oxides for All-Solid-State Li-Ion Batteries
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Materials
Volume 10
Issue 10
10.3390/ma10101186
materials-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Influence of the Polymer Amount on the Biological Properties of PCL/ZrO2 Hybrid Materials Synthesized via Sol-Gel Technique

by
Michelina Catauro
1,*,
Elisabetta Tranquillo
1,2,
Michela Illiano
2,
Luigi Sapio
2,
Annamaria Spina
2 and
Silvio Naviglio
2
1
Department of Industrial and Information Engineering, University of Campania “Luigi Vanvitelli”, Via Roma 29, 81031 Aversa, Italy
2
Department of Biochemistry, Biophysics and General Pathology, Medical School, University of Campania “Luigi Vanvitelli”, Via L. De Crecchio 7, 80138 Naples, Italy
*
Author to whom correspondence should be addressed.
Materials 2017, 10(10), 1186; https://doi.org/10.3390/ma10101186
Submission received: 21 August 2017 / Revised: 10 October 2017 / Accepted: 13 October 2017 / Published: 17 October 2017
(This article belongs to the Special Issue Sol-Gel Chemistry Applied to Materials Science)
Browse Figures
Versions Notes

Abstract

:
Organic/inorganic hybrid materials are attracting considerable attention in the biomedical area. The sol-gel process provides a convenient way to produce many bioactive organic–inorganic hybrids. Among those, poly(e-caprolactone)/zirconia (PCL/ZrO2) hybrids have proved to be bioactive with no toxic materials. The aim of this study was to investigate the effects of these materials on the cellular response as a function of the PCL content, in order to evaluate their potential use in the biomedical field. For this purpose, PCL/ZrO2 hybrids containing 6, 12, 24, and 50 wt % of PCL were synthesized by the sol-gel method. The effects of their presence on the NIH-3T3 fibroblast cell line carrying out direct cell number counting, MTT, cell damage assays, flow cytometry-based analysis of cell-cycle progression, and immunoblotting experiments. The results confirm and extend the findings that PCL/ZrO2 hybrids are free from toxicity. The hybrids containing 12 and 24 wt % PCL, (more than 6 and 50 wt % ones) enhance cell proliferation when compared to pure ZrO2 by affecting cell cycle progression. The finding that the content of PCL in PCL/ZrO2 hybrids differently supports cell proliferation suggests that PCL/ZrO2 hybrids could be useful tools with different potential clinical applications.

1. Introduction

Organic/inorganic hybrid materials are attracting considerable attention today. They are biphasic systems in which the organic and inorganic components are connected on a nanometer scale. A classification of the hybrid materials based on interactions between the phases was proposed by Judenstein and Sanchez [1]. They defined these materials as first and second class hybrids. In particular, Class I consists of organic and inorganic compounds bonded through hydrogen, van der Waals, or ionic bonds, whereas in Class II, the organic and inorganic phases are linked through strong chemical bonds (covalent or polar covalent bonds). Many organic/inorganic hybrid materials can be developed using the sol-gel method. The sol-gel chemistry is based on the hydrolysis and polycondensation reactions of the precursor metal alkoxides M(OR)x, where M represents a network-forming element (such as Si, Sn, Zr, Ti, Al), and R is usually an alkyl group. The sol-gel reactions are dependent on many parameters, such as structure and concentration of the reactants, solvents, and catalysts, as well as reaction temperature and rate of removal of by-products and solvents [2,3]. The sol-gel process provides a convenient way to produce porous [4], biocompatible, and bioactive materials [5]. The last property is due to the presence of –OH groups on the material surface, which can promote apatite layer formation on the biomaterial surface [6]. Therefore, sol-gel materials may be easily osseointegrated when implanted in vivo [7,8]. This is a property required for a material to be used in the dental and orthopedic fields. Moreover, the sol-gel method shows several advantages over most traditional syntheses. It gives homogeneous materials and leads to a fine control of the chemical composition. The low processing temperature allows one to add thermolabile molecules, such as polymers, drugs, and/or biomolecules, to the glassy matrix [9], obtaining organic/inorganic hybrids. The main idea, when a hybrid material is developed, is to overcome the disadvantages of each of the components and to retain their advantages. Among the synthetic polymers, poly(e-caprolactone) (PCL), which is a biodegradable aliphatic polyester [10,11,12], has already been proposed for many biomedical applications, such as drug delivery and tissue engineering [12,13,14,15,16,17,18,19,20,21]. However, PCL is too flexible and weak to satisfy the mechanical requirements for this specific application, while polymer-based nanocomposite materials provide an alternative choice to overcome these problems [22,23,24,25]. On the other hand, it is known that glass matrices, such as zirconia, are bioactive and biocompatible [26,27], but they cannot be used in some applications due to their poor mechanical properties.
Elsewhere, Catauro et al. proposed the use of organic/inorganic hybrid materials based on zirconia (ZrO2), with different percentages of PCL embedded, for biomedical applications [28]. These materials were extensively characterized [29]. The presence of hydrogen bonds between the carboxylic groups of the polymer and the hydroxyl groups of the inorganic matrix was proved by Fourier transform infrared (FTIR) analysis, and is strongly supported by solid-state NMR [29]. SEM analysis confirmed that they can be considered hybrid materials and no appreciable difference between their morphologies was observed [29]. Furthermore, the materials are nanocomposites, as shown by AFM analysis [30]. XRD diffractograms showed that ZrO2/PCL gel exhibits broad humps that are characteristic of amorphous materials, even though the PCL diffractogram showed the sharp peaks typical of a crystalline material [31].
PCL/ZrO2 hybrids were proposed as matrices for the controlled release of drugs [30], or as coatings able to improve the biological properties of bio-inert titanium implants or to release drugs in a controlled manner [28,32]. The obtained films, indeed, appeared to be more bioactive and biocompatible than uncoated titanium. The coatings induced the formation of hydroxyapatite when soaked in SBF, did not show cytotoxicity and were also supportive of cell proliferation at all compositions. In order to evaluate the potential use of such materials as biomaterials, further knowledge about their biological properties is needed. Therefore, the aim of the present study has been to investigate, more in depth, the effects of the presence of PCL/ZrO2 materials as a function of the PCL content on the NIH-3T3 fibroblast cellular response and the underlying mechanisms. Therefore, five PCL/ZrO2 hybrid samples containing different amount of PCL (6, 12, 24, and 50 wt %) have been synthesized via the sol-gel route as reported elsewhere [29] and the effects of their presence on cell viability and cell cycle progression, as well as membrane integrity have been evaluated. All of the results are reported as a function of PCL content.

2. Results and Discussion

2.1. PCL/ZrO2 Hybrid Materials Do Not Have Cytotoxic Effects

The mouse NIH-3T3 cell line is a well-established model system of fibroblasts, largely used to study cellular responses, including those induced by biomaterials [33,34,35,36,37,38].
In order to evaluate the cytotoxicity of the bioactive PCL/ZrO2 hybrid materials (synthesized as shown in the Materials and Methods section) as a function of PCL content, NIH-3T3 fibroblasts were grown in the absence and presence of the pure ZrO2 and PCL/ZrO2 hybrid materials, each containing different percentages (6, 12, 24, 50 wt %) of PCL, for up to 72 h. Over the time course, the plates were observed daily under phase-contrast microscopy and relative pictures were taken (Figure 1). Notably, in Figure 1 it is shown that the cells grown in the presence of our preparations appeared not to suffer and shared a morphology similar to that of control untreated cells. In addition, it is also observed that the 12% and 24% PCL/ZrO2 hybrids treated plates contain more cells as compared to plates treated with PCL-free ZrO2, 6% and 50% PCL/ZrO2 hybrids, with a cell density similar to that of control untreated plate.
Then, cells were detached from monolayers by brief exposure to a solution of trypsin and a Trypan Blue dye exclusion assay was performed (Figure 2). Interestingly, Figure 2 shows that the number of Trypan Blue positive dead cells increased in the presence of pure ZrO2 (≈15%) as compared to control untreated cells, with less evident variations in the presence of PCL/ZrO2 hybrid materials.
Finally, we recovered the culturing medium in which NIH-3T3 fibroblasts were grown, and tested it, by using the Abbott Lab Chemistry Analyzer ci 8200 (usually used to test blood samples), looking for the presence of any known intracellular enzymatic activities, such as lactate dehydrogenase, (LDH), aspartate aminotransferase (AST), and alanine aminotransferase (ALT) [39,40], to evaluate their release upon possible cell damage in response to the materials (Table 1). The results, reported in Table 1, show a clear increase of both LDH and AST activities in media from NIH-3T3 fibroblasts treated with the cytotoxic agent doxorubicin (DOXO) (1 µM) (used as positive control) [41] as compared to the untreated ones. Moreover, media from plates without cells were tested as a negative control. In addition, total proteins and ALT transaminase were measured as further internal controls [40]. As expected, according to the absence of ALT activity in fibroblasts [42,43], no increase of such activity is seen in any samples.
Remarkably, Table 1 shows that no increase of AST transaminase activity is detected in medium from NIH-3T3 fibroblasts grown for 72 h in the presence of PCL/ZrO2 hybrid materials, as compared to the PCL-free ZrO2, whereas only a very slight increase of LDH activity (from 61 to 64 U/L) is recorded. This results suggests that minimal, if any, cell membrane injury occurs in response to PCL/ZrO2 hybrid materials.
Overall, the above data clearly indicate that the content of PCL in the PCL/ZrO2 hybrid materials does not cause cell damage on NIH-3T3 fibroblasts.

2.2. PCL Content in the PCL/ZrO2 Hybrids Positively Affects the Cell Proliferation

To test the influence of PCL content on cell proliferation, NIH-3T3 fibroblasts were grown for 24 and 48 h in 10% serum containing medium in the absence (control cells) or presence of the following preparations: PCL-free ZrO2 and PCL/ZrO2 hybrid materials with different percentages (6 wt %, 12 wt %, 24 wt %, 50 wt %) of PCL. Thereafter, cell proliferation was determined by direct cell number counting and by conventional MTT assay (Figure 3).
Figure 3 shows that the cell population is significantly higher, at both time points, in plates containing 12 wt % and 24 wt % PCL/ZrO2 hybrid materials, as compared to cell plates cultured in the presence of pure ZrO2, whereas no significant variations in cell number are evident in the presence of 6 wt % and 50 wt % PCL/ZrO2 hybrid materials. In agreement with previous findings [34,44], a decrease of cell number and cell viability in response to PCL-free ZrO2 is evident as compared to control fibroblasts (grown in the absence of materials), according to a growth impairment induced by such material. Recently, indeed, Meesser et al. [44] proved that most ceramics cause a mild suppression of cell functions in vitro. However, the levels of the suppression observed would be acceptable on the basis of standards used to evaluate alloys and composites (<25% suppression of dehydrogenases activity).
Altogether, the above results suggest that the PCL/ZrO2 hybrids, mainly those containing 12 wt % and 24 wt % PCL, positively affect cell proliferation when compared to the inorganic material in the non-hybrid form. Our data are in agreement with previous similar findings based mainly on cell viability MTT assay [28,34], supporting the evidence that the presence of different PCL amounts favors the preparation of biomaterials with improved biocompatibility. In fact, it is known that its slow degradation kinetics, biocompatibility, and semicrystalline nanofibers can result in stimulation of the extracellular matrix providing a good scaffold for cell proliferation and engineering [25,45].
The slightly lower positive effect observed in the plate containing the system with 6 wt % PCL as compared to those ones containing 12 wt % and 24 wt % suggests that when the polymer is added at a low level, the effect of the ZrO2 matrix predominates. Probably, the inorganic network masks the polymer that is embedded and linked within it by the formation of –OH bonds. On the other hand, the decrease of the positive effect recorded when the PCL content is higher than 24%, is in agreement with other works in literature [46,47], which ascribed the effect of slight inhibition to the hydrophobic nature of PCL inhibitings cells adhesion. This, in turn, hinders cell proliferation, and thus causes a decrease of cells vitality. However, it has been proven [48] that the addition of hydrophilic SiO2 to PCL coatings leads to an increase of coating hydrophilicity. Therefore, up to 24 wt % of PCL the presence of zirconia matrix make the synthesized hybrid materials hydrophilic and the negative effect of PCL is observed only for higher polymer amounts. The dependence between cell proliferation and the PCL content can be due to a different degradation rate of the polymer in the different hybrid materials. It is reported in literature that a high PCL degradation rate negatively affects cell proliferation [22,23,24,25] and when 50 wt % of polymer is added in the zirconia matrix, part of the PCL cannot forms H-bonds because all hydroxyl groups of the matrix are already involved in H-bonds. Therefore, the polymer can be highly subjected to degradation process. This is in accordance with the results of Vecchio Ciprioti et al.[49], who showed the protective role of the zirconia matrix in ZrO2/PEG hybrid materials against the thermal degradation of the polymer. To increase the specificity and reliability of the above data, we tested the effects of the five formulations on NIH-3T3 cell proliferation, also in a different experimental growth condition, i.e., by culturing fibroblasts in low serum (1%) containing medium for 24 and 48 h. As expected, in all 1% serum samples we found less cells when compared to the 10% serum samples (Figure 4) [50]. Interestingly, Figure 4 also shows that the cell population again is higher in plates containing 12 wt % and 24 wt % PCL/ZrO2 hybrid materials, as compared to cell plates cultured in presence of the PCL-free ZrO2.
Overall, these data confirm that even in low serum conditions, i.e., in adverse growth conditions, no deleterious cytotoxic effect due to PCL content in PCL/ZrO2 hybrid materials could be seen and also that the hybrids with PCL percentages of 12 wt % and 24 wt % result in a growth advantage to NIH-3T3 fibroblasts.

2.3. PCL Content in the PCL/ZrO2 Hybrids Affects the Cell Cycle Progression

To further explore the influence of PCL content on NIH-3T3 cell proliferation, the distribution of cells in the G0/G1, S, G2/M cell cycle phases was evaluated by flow cytometric analysis of propidium iodide-stained cells. (Figure 5). The sub-G1 population (i.e., the proportion of cells with hypoploid DNA content), characteristic of cells having undergone DNA fragmentation (the biochemical hallmark of apoptotic cell death) was also looked at. Firstly, Figure 5 shows that the percentages of asynchronously growing control NIH-3T3 fibroblasts in the G0/G1, S, and G2/M phases are 49%, 42%, 9%, respectively, in full agreement with previous result [51]. Notably, in agreement with the described weak cytotoxic effect of PCL-free ZrO2 [34,44] (Figure 2), in Figure 5 the appearance of a sub-G1 cell death population (7%) was observed in ZrO2 pure treated cells, as compared to control untreated cells, whereas such a sub-G1 population is either completely absent or only present to a low extent in PCL/ZrO2 hybrid materials, suggesting a protective/growth supporting effect of the PCL component. In addition, interestingly, fibroblasts grown in the presence of 12 wt % PCL/ZrO2 hybrid materials accumulate more in the S phase (62%), whereas fibroblasts grown in the presence of 24 wt % PCL/ZrO2 hybrid materials have a more evident G0/G1 phase (53%) compared to those cultured in the presence of PCL-free ZrO2, suggesting that the PCL content can differently affect cell cycle progression. These results are in accordance with the data obtained via cell counting and the MTT assay. The different modification of the cell cycle progression, indeed, may be attributed to the different concentration of the PCL degradation products in the medium, due to the different PCL degradation rate in the hybrid system [52,53]. This, in turn, can differently affect the pathway(s) involved in the progression of the cell cycle [22,23,24,25].
To obtain further insights into the possible effects of PCL/ZrO2 hybrid materials on the cell division cycle of NIH-3T3 cells, we studied the expression of some relevant cell cycle regulating proteins in response to the following preparations: ZrO2 and PCL/ZrO2 hybrid materials with different percentages (6 wt %, 12 wt %, 24 wt %, 50 wt %) of PCL (Figure 5B).
To this aim, NIH-3T3 cells were exposed to the materials for 48 h. The cell extracts were analyzed by Western blotting to examine the levels of cyclin-dependent kinase inhibitor p27 and of cyclin A proteins.
Remarkably, it was noted that cyclin A and p27 protein levels, as well as those of other relevant cell cycle proteins, oscillate depending on cell cycle phases and are strongly involved in cell cycle progression [50,54,55]. In Figure 5B it is shown that the amounts of the positive cell cycle regulator cyclin A and of cell cycle inhibitor p27 increased and decreased, respectively, in response to PCL/ZrO2 hybrid materials. Moreover, there is evidence that p27 (that is a cell cycle inhibitor) is more abundant in ZrO2 pure treated cells when compared to control untreated cells and decreases in response to hybrids, whereas cyclin A (that is a positive regulator of cell cycle) increases (Figure 5B). Interestingly, this is in agreement with the growth promoting effect of the hybrid materials, as compared to PCL-free ZrO2 which, on the contrary, has a growth inhibitory effect. Overall, the above cell cycle and Western blot data suggest that 12 wt % and 24 wt % PCL/ZrO2 hybrid materials affect the cell cycle progression of NIH-3T3 cells more than the others compositions.

3. Materials and Methods

3.1. Sol-Gel Synthesis

The organic/inorganic PCL/ZrO2 hybrids materials, containing 0, 6, 12, 24, and 50 wt % of the organic component, were synthesized by the sol-gel process as elsewhere [29]. A zirconium(IV) propoxide solution (Zr(OC3H7)4 70 wt % in n-propanol, Sigma Aldrich) and PCL (Mn = 10,000) were used as precursors of the inorganic and organic phases, respectively. A solution of PCL in chloroform was added to the solution of Zr(OC3H7)4 in an ethanol–acetylacetone–water mixture. Acetylacetone was used to control the hydrolytic activity of zirconium alkoxide. The solution was stirred by a magnetic stirrer until the resulting sols were uniform and homogeneous. The molar ratios between the reagent achieved were: CH3CH2OH/Zr(OCH2CH2CH3)4 = 5.7; Zr(OCH2CH2CH3)4/AcAc = 4.5.
After gelation, all of the wet gels were air dried at 45 °C for 48 h to remove residual solvents without any polymer degradation. As indicated in the text, Figure 6 shows the flow chart of hybrid synthesis by the sol-gel method.

3.2. Cell Culture and Treatments

The mouse fibroblast NIH-3T3 cell line was obtained from the American Type Culture Collection (Rockville, MD, USA). NIH-3T3 cells were grown in Dulbecco′s Modified Eagle′s Medium (DMEM) supplemented with 2 mM glutamine, 100 U/mL penicillin, 100 mg/mL streptomycin, and 10% fetal bovine serum (FBS), and cultured at 37 °C in a 5% CO2 humidified atmosphere. Typically, cells were split (5 × 105/10 cm plate, 6 × 104/6-well plate) and grown in 10% serum containing medium. After 24 h, the medium was removed, the cells were washed with PBS and incubated with 10% (in some experiments 1%) FBS fresh medium (Time 0), in the absence (control cells) or in the presence of the organic/inorganic PCL/ZrO2 hybrid materials, at 0.3 mg/mL concentration, containing 0, 6, 12, 24, and 50 wt % of the organic component PCL and grown for the times indicated in the text and figures. After treatment, both floating cells and adherent cells were recovered and counted (by centrifugation from culture medium and harvested by trypsinization, respectively). In the case of experiments designed for fluorescence-activated cell sorting (FACS) analysis and the evaluation of the level of proteins involved in cell cycle progression, adherent cells were collected, washed twice with ice-cold PBS, and divided into two aliquots (see below).

3.3. Trypan Blue Exclusion Test

The Trypan Blue (dye) exclusion test is used to determine the number of dead cells present in a cell suspension. Briefly, cells were seeded in 10% PBS-containing medium in a 6-well plate at a density of 6 × 104 cell/well for 24 and 48 h at 37 °C and cultured, as above. At the indicated times, after cell collection, cell counting was performed by mixing 10 μL of cell suspension with an equal volume of Trypan Blue (TB; 0.4%, v/v). The number of blue staining cells (dead cells) and of viable cells (that exclude the Trypan Blue) was recorded. TB experiments were performed three times (in replicates of six wells for each data point in each experiment). Data are presented as means ± standard deviation for a representative experiment.

3.4. Cell Viability Assay

Cell viability assay was performed, as described previously [41]. Briefly, cells were seeded in 10% PBS-containing medium in a 96-well plate at a density of 3 × 103 cells/well for 24 and 48 h at 37 °C and cultured, as above. Viable cells were determined by the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay and cell viability was assessed by adding MTT solution in PBS to a final concentration of 0.5 mg/mL. The plates were then incubated at 37 °C for 4 h and the MTT-formazan crystals were solubilized in a solution of 4% 1N isopropanol/hydrochloric acid at 37 °C on a shaking table for 20 min. The absorbance values of the solution in each well were measured at 570 nm using a Bio-Rad 550 microplate reader (Bio-Rad Laboratories, Milan, Italy). Cell viability was expressed as a percentage of absorbance values in treated samples with respect to that of control (100%). MTT experiments were performed three times (in replicates of 6 wells for each data point in each experiment). Data are presented as means ± standard deviation for a representative experiment.

3.5. Evaluation of Cell Cycle Phases by Flow Cytometry

After treatment, the cells were recovered as previously described in “Cell culture and treatments”, fixed by resuspension in 70% ice-cold methanol/PBS and incubated overnight at 4 °C. The cells were then centrifuged at 1200 RPM ((revolutions per minute) for 5 min, and the pellets obtained were washed with ice-cold PBS, centrifuged for 5 min, resuspended in 0.5 mL DNA staining solution (50 μg/mL PI and 100 μg RNase A in PBS), and incubated overnight at 37 °C in the dark. The samples were then transferred to 5-mL Falcon tubes and stored oin ice until assayed. Flow cytometry analysis was performed using a FACSCalibur flow cytometer (Becton Dickinson, San Jose, CA, USA) interfaced with a Hewlett-Packard computer (model 310) for data analysis. For the evaluation of intracellular DNA content, at least 20,000 events for each point were analyzed, and regions were set up to acquire quantitative data of cells that fell into the normal G1, S, and G2/M regions [50]. Results were analyzed using ModiFIT Cell Cycle Analysis software (Version 3.0, verity software house, Inc., Topsham, ME, USA).

3.6. Preparation of Cell Lysates

Cell extracts were prepared as previously described [41]. Briefly, after treatments, the cells were recovered as previously described in “Cell culture and treatments”; 3–5 volumes of RIPA buffer (PBS, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS) containing 10 μg/mL aprotinin, leupeptin, and 1 mM phenylmethylsulfonyl fluoride (PMSF) were added to the recovered cells. After incubation on ice for 1 h, samples were centrifuged at 18,000 g in an Eppendorf microcentrifuge for 15 min at 4 °C and the supernatant (SDS total extract) was recovered. Some aliquots were taken for protein quantification according to the Bradford method; others were diluted in 4× (to be used at 1:4 dilution) Laemmli buffer, boiled and stored as samples for immunoblotting analysis.

3.7. Western Blot Analysis

Typically, we employed 20–40 μg of total extracts for immunoblotting [56]. Proteins from cell preparations were separated by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto nitrocellulose sheets (Schleicher & Schuell, Dassel, Germany) by a Mini Trans-Blot apparatus (BioRad, Hercules, CA, USA). Membranes were washed in TBST (10 mM Tris, pH 8.0, 150 mM NaCl, 0.05% Tween 20), and were blocked with TBST supplemented with 5% nonfat dry milk. Then the membranes were incubated with different primary antibodies in TBST and 5% nonfat dry milk, washed, and incubated with horseradish peroxide-conjugated secondary goat anti-rabbit or anti-mouse antibodies, conjugated with horseradish peroxidase (BioRad). Enhanced chemiluminescence detection reagents were used as a detection system (ECL), according to the manufacturer’s instructions (Amersham Biosciences, Little Chalfont, UK).

3.8. Statistical Analysis

Most of the experiments were performed at least three times with replicate samples, except where otherwise indicated. Data are plotted as mean ± SD (standard deviation). The means were compared using analysis of variance (ANOVA) plus Bonferroni’s t-test. p values of less than 0.05 were considered significant.

4. Conclusions

Organic/inorganic hybrid materials represent a very attractive field in biomedical area. The sol-gel method provides a versatile way to produce bioactive hybrid materials and many organic/inorganic hybrids, including poly(e-caprolactone)/Zirconia (PCL/ZrO2), have been developed by the sol-gel process.
In this study, we describe by multiple assays (including those aimed to test the release of intracellular enzymatic activities such as transaminases and lactate dehydrogenase upon cell damage), that PCL/ZrO2 hybrid materials are free from toxicity. We also provide interesting evidence that the hybrids containing 12 wt % and 24 wt % PCL, more than 6 wt % and 50 wt % ones, enhance cell proliferation when compared to PCL-free ZrO2, and impacted cell cycle progression.
The underlying molecular mechanisms by which PCL/ZrO2 hybrid materials support cell cycle progression and cell proliferation, remain unclear and need to be investigated. It is to be noted that we are planning this for future studies. Overall, whatever the exact mechanism(s), our results enrich the evidence of favourable biological properties of PCL/ZrO2 hybrid materials and suggest the further development of such hybrids for dental and orthopedic applications.

Author Contributions

M.C. and S.N. conceived and designed the experiments and wrote the paper; M.C. assisted by E.T. performed the material synthesis; MI., L.S. and E.T. performed the biological experiments; A.S. analyzed the experimental data.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Judeinstein, P.; Sanchez, C. Hybrid organic-inorganic materials: A land of multidisciplinarity. J. Mater. Chem. 1996, 6, 511–525. [Google Scholar] [CrossRef]
  2. Brinker, C.J.; Scherer, G.W. Sol-Gel Science: The Physics and Chemistry of Sol-Gel Processing; Academic Press: Cambridge, MA, USA, 2013. [Google Scholar]
  3. Klein, L.C. Sol-Gel Technology for Thin Films, Fibers, Preforms, Electronics, and Specialty Shapes; William Andrew Publishing: Norwich, NY, USA, 1988. [Google Scholar]
  4. Lu, B.; Lin, Y. Sol-gel synthesis and characterization of mesoporous yttria-stabilized zirconia membranes with graded pore structure. J. Mater. Sci. 2011, 46, 7056–7066. [Google Scholar] [CrossRef]
  5. Catauro, M.; Papale, F.; Sapio, L.; Naviglio, S. Biological influence of Ca/P ratio on calcium phosphate coatings by sol-gel processing. Mater. Sci. Eng. C 2016, 65, 188–193. [Google Scholar] [CrossRef] [PubMed]
  6. Kokubo, T.; Kim, H.-M.; Kawashita, M. Novel bioactive materials with different mechanical properties. Biomaterials 2003, 24, 2161–2175. [Google Scholar] [CrossRef]
  7. Gupta, R.; Kumar, A. Bioactive materials for biomedical applications using sol-gel technology. Biomed. Mater. 2008, 3, 034005. [Google Scholar] [CrossRef] [PubMed]
  8. Martin, R.A.; Yue, S.; Hanna, J.V.; Lee, P.; Newport, R.J.; Smith, M.E.; Jones, J.R. Characterizing the hierarchical structures of bioactive sol–gel silicate glass and hybrid scaffolds for bone regeneration. Phil. Trans. R. Soc. A 2012, 370, 1422–1443. [Google Scholar] [CrossRef] [PubMed]
  9. Sanchez, C.; Ribot, F. Design of hybrid organic-inorganic materials synthesized via sol-gel chemistry. New J. Chem. 1994, 18, 1007–1047. [Google Scholar]
  10. Eldsäter, C.; Erlandsson, B.; Renstad, R.; Albertsson, A.-C.; Karlsson, S. The biodegradation of amorphous and crystalline regions in film-blown Poly (ϵ-caprolactone). Polymer 2000, 41, 1297–1304. [Google Scholar] [CrossRef]
  11. Choi, E.J.; Kim, C.H.; Park, J.K. Synthesis and characterization of starch-g-polycaprolactone copolymer. Macromolecules 1999, 32, 7402–7408. [Google Scholar] [CrossRef]
  12. Causa, F.; Battista, E.; Della Moglie, R.; Guarnieri, D.; Iannone, M.; Netti, P.A. Surface investigation on biomimetic materials to control cell adhesion: The case of rgd conjugation on PCL. Langmuir 2010, 26, 9875–9884. [Google Scholar] [CrossRef] [PubMed]
  13. Zhong, Z.; Sun, X.S. Properties of soy protein isolate/polycaprolactone blends compatibilized by methylene diphenyl diisocyanate. Polymer 2001, 42, 6961–6969. [Google Scholar] [CrossRef]
  14. De Santis, R.; Gloria, A.; Russo, T.; D’Amora, U.; Zeppetelli, S.; Dionigi, C.; Sytcheva, A.; Herrmannsdörfer, T.; Dediu, V.; Ambrosio, L. A basic approach toward the development of nanocomposite magnetic scaffolds for advanced bone tissue engineering. J. Appl. Polym. Sci. 2011, 122, 3599–3605. [Google Scholar] [CrossRef]
  15. Hutmacher, D.W.; Schantz, T.; Zein, I.; Ng, K.W.; Teoh, S.H.; Tan, K.C. Mechanical properties and cell cultural response of polycaprolactone scaffolds designed and fabricated via fused deposition modeling. J. Biomed. Mater. Res. A 2001, 55, 203–216. [Google Scholar] [CrossRef]
  16. Kyriakidou, K.; Lucarini, G.; Zizzi, A.; Salvolini, E.; Mattioli Belmonte, M.; Mollica, F.; Gloria, A.; Ambrosio, L. Dynamic co-seeding of osteoblast and endothelial cells on 3d polycaprolactone scaffolds for enhanced bone tissue engineering. J. Bioact. Compat. Polym. 2008, 23, 227–243. [Google Scholar] [CrossRef]
  17. Bañobre-López, M.; Pineiro-Redondo, Y.; De Santis, R.; Gloria, A.; Ambrosio, L.; Tampieri, A.; Dediu, V.; Rivas, J. Poly (caprolactone) based magnetic scaffolds for bone tissue engineering. J. Appl. Phys. 2011, 109, 07B313. [Google Scholar] [CrossRef]
  18. Bartolo, P.; Domingos, M.; Gloria, A.; Ciurana, J. Biocell printing: Integrated automated assembly system for tissue engineering constructs. CIRP Ann.-Manuf. Technol. 2011, 60, 271–274. [Google Scholar] [CrossRef]
  19. Catauro, M.; Bollino, F.; Papale, F.; Piccolella, S.; Pacifico, S. Sol-gel synthesis and characterization of SiO2/PCL hybrid materials containing quercetin as new materials for antioxidant implants. Mater. Sci. Eng. C 2016, 58, 945–952. [Google Scholar] [CrossRef] [PubMed]
  20. Domingos, M.; Chiellini, F.; Gloria, A.; Ambrosio, L.; Bartolo, P.; Chiellini, E. Effect of process parameters on the morphological and mechanical properties of 3d bioextruded poly (ϵ-caprolactone) scaffolds. Rapid Prototyp. J. 2012, 18, 56–67. [Google Scholar] [CrossRef]
  21. Catauro, M.; Bollino, F. Anti-inflammatory entrapment in polycaprolactone/silica hybrid material prepared by sol-gel route, characterization, bioactivity and in vitro release behavior. J. Appl. Biomater. Funct. Mater. 2013, 11, 172–179. [Google Scholar] [CrossRef] [PubMed]
  22. Ghorbani, F.; Moradi, L.; Shadmehr, M.B.; Bonakdar, S.; Droodinia, A.; Safshekan, F. In-vivo characterization of a 3d hybrid scaffold based on PCL/decellularized aorta for tracheal tissue engineering. Mater. Sci. Eng. C 2017, 81, 74–83. [Google Scholar] [CrossRef] [PubMed]
  23. Perrin, D.E.; English, J.P. Polycaprolactone. In Handbook of Biodegradable Polymers; Domb, A.J., Kost, J.K., Wiseman, D.M., Eds.; CRC Press: Amsterdam, The Netherlands, 1997; Volume 7, pp. 63–77. [Google Scholar]
  24. Lee, S.J.; Liu, J.; Oh, S.H.; Soker, S.; Atala, A.; Yoo, J.J. Development of a composite vascular scaffolding system that withstands physiological vascular conditions. Biomaterials 2008, 29, 2891–2898. [Google Scholar] [CrossRef] [PubMed]
  25. Sung, H.-J.; Meredith, C.; Johnson, C.; Galis, Z.S. The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis. Biomaterials 2004, 25, 5735–5742. [Google Scholar] [CrossRef] [PubMed]
  26. Catauro, M.; Bollino, F.; Papale, F. Biocompatibility improvement of titanium implants by coating with hybrid materials synthesized by sol-gel technique. J. Biomed. Mater. Res. A 2014, 102, 4473–4479. [Google Scholar] [CrossRef] [PubMed]
  27. Catauro, M.; Bollino, F.; Papale, F.; Mozzati, M.C.; Ferrara, C.; Mustarelli, P. ZrO2/PEG hybrid nanocomposites synthesized via sol-gel: Characterization and evaluation of the magnetic properties. J. Non-Cryst. Solids 2015, 413, 1–7. [Google Scholar] [CrossRef]
  28. Catauro, M.; Bollino, F.; Papale, F.; Mozetic, P.; Rainer, A.; Trombetta, M. Biological response of human mesenchymal stromal cells to titanium grade 4 implants coated with PCL/ZrO2 hybrid materials synthesized by sol-gel route: In vitro evaluation. Mater. Sci. Eng. C 2014, 45, 395–401. [Google Scholar] [CrossRef] [PubMed]
  29. Catauro, M.; Mozzati, M.C.; Bollino, F. Sol–gel hybrid materials for aerospace applications: Chemical characterization and comparative investigation of the magnetic properties. Acta Astronaut. 2015, 117, 153–162. [Google Scholar] [CrossRef]
  30. Catauro, M.; Raucci, M.; Ausanio, G. Sol-gel processing of drug delivery zirconia/polycaprolactone hybrid materials. J. Mater. Sci.-Mater. M 2008, 19, 531–540. [Google Scholar] [CrossRef] [PubMed]
  31. Catauro, M.; Bollino, F.; Papale, F. Preparation, characterization, and biological properties of organic-inorganic nanocomposite coatings on titanium substrates prepared by sol-gel. J. Biomed. Mater. Res. A 2014, 102, 392–399. [Google Scholar] [CrossRef] [PubMed]
  32. Catauro, M.; Bollino, F.; Papale, F.; Pacifico, S.; Galasso, S.; Ferrara, C.; Mustarelli, P. Synthesis of zirconia/polyethylene glycol hybrid materials by sol-gel processing and connections between structure and release kinetic of indomethacin. Drug Deliv. 2014, 21, 595–604. [Google Scholar] [CrossRef] [PubMed]
  33. Naviglio, S.; Spina, A.; Chiosi, E.; Fusco, A.; Illiano, F.; Pagano, M.; Romano, M.; Senatore, G.; Sorrentino, A.; Sorvillo, L. Inorganic phosphate inhibits growth of human osteosarcoma U2OS cells via adenylate cyclase/camp pathway. J. Cell. Biochem. 2006, 98, 1584–1596. [Google Scholar] [CrossRef] [PubMed]
  34. Catauro, M.; Papale, F.; Bollino, F.; Gallicchio, M.; Pacifico, S. Biological evaluation of zirconia/peg hybrid materials synthesized via sol-gel technique. Mater. Sci. Eng. C 2014, 40, 253–259. [Google Scholar] [CrossRef] [PubMed]
  35. Ramanathan, G.; Singaravelu, S.; Muthukumar, T.; Thyagarajan, S.; Perumal, P.T.; Sivagnanam, U.T. Design and characterization of 3d hybrid collagen matrixes as a dermal substitute in skin tissue engineering. Mater. Sci. Eng. C 2017, 72, 359–370. [Google Scholar] [CrossRef] [PubMed]
  36. Park, J.; Lee, S.J.; Chung, S.; Lee, J.H.; Kim, W.D.; Lee, J.Y.; Park, S.A. Cell-laden 3d bioprinting hydrogel matrix depending on different compositions for soft tissue engineering: Characterization and evaluation. Mater. Sci. Eng. C 2017, 71, 678–684. [Google Scholar] [CrossRef] [PubMed]
  37. Ivanova, S.I.; Chakarov, S.; Momchilova, A.; Pankov, R. Live-cell biosensor for assessment of adhesion qualities of biomaterials. Mater. Sci. Eng. C 2017, 78, 230–238. [Google Scholar] [CrossRef] [PubMed]
  38. Navarro, L.; Mogosanu, D.-E.; Ceaglio, N.; Luna, J.; Dubruel, P.; Rintoul, I. Novel poly (diol sebacate) s as additives to modify paclitaxel release from poly (lactic-co-glycolic acid) thin films. J. Pharm. Sci. 2017, 106, 2106–2114. [Google Scholar] [CrossRef] [PubMed]
  39. Morgenstern, S.; Flor, R.; Kessler, G.; Klein, B. Automated determination of nad-coupled enzymes. Determination of lactic dehydrogenase. Anal. Biochem. 1965, 13, 149–161. [Google Scholar] [CrossRef]
  40. Ferri, F.F. Ferri’s Best Test E-Book: A Practical Guide to Laboratory Medicine and Diagnostic Imaging, 3rd ed.; Elsevier Health Sciences: Philadelphia, PA, USA, 2014. [Google Scholar]
  41. Spina, A.; Sorvillo, L.; Di Maiolo, F.; Esposito, A.; D’Auria, R.; Di Gesto, D.; Chiosi, E.; Naviglio, S. Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway. J. Cell. Physiol. 2013, 228, 198–206. [Google Scholar] [CrossRef] [PubMed]
  42. McKeehan, W.L. Glutaminolysis in animal cells. In Carbohydrate Metabolism in Cultured Cells; Morgan, M.J., Ed.; Springer: Boston, MA, USA, 1986; pp. 111–150. [Google Scholar]
  43. Sekiya, S.; Suzuki, A. Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors. Nature 2011, 475, 390–393. [Google Scholar] [CrossRef] [PubMed]
  44. Messer, R.L.; Lockwood, P.E.; Wataha, J.C.; Lewis, J.B.; Norris, S.; Bouillaguet, S. In vitro cytotoxicity of traditional versus contemporary dental ceramics. J. Prosthet. Dent. 2003, 90, 452–458. [Google Scholar] [CrossRef]
  45. Sims-Mourtada, J.; Niamat, R.A.; Samuel, S.; Eskridge, C.; Kmiec, E.B. Enrichment of breast cancer stem-like cells by growth on electrospun polycaprolactone-chitosan nanofiber scaffolds. Int. J. Nanomed. 2014, 9, 995–1003. [Google Scholar] [CrossRef] [PubMed]
  46. Allo, B.A.; Rizkalla, A.S.; Mequanint, K. Hydroxyapatite formation on sol-gel derived poly (ε-caprolactone)/bioactive glass hybrid biomaterials. ACS Appl. Mater. Interfaces 2012, 4, 3148–3156. [Google Scholar] [CrossRef] [PubMed]
  47. Catauro, M.; Bollino, F.; Papale, F. Surface modifications of titanium implants by coating with bioactive and biocompatible poly (ε-caprolactone)/sio 2 hybrids synthesized via sol-gel. Arab. J. Chem. 2015. [Google Scholar] [CrossRef]
  48. Teng, S.-H.; Wang, P.; Dong, J.-Q. Bioactive hybrid coatings of poly (ε-caprolactone)–silica xerogel on titanium for biomedical applications. Mater. Lett. 2014, 129, 209–212. [Google Scholar] [CrossRef]
  49. Ciprioti, S.V.; Bollino, F.; Tranquillo, E.; Catauro, M. Synthesis, thermal behavior and physicochemical characterization of ZrO2/PEG inorganic/organic hybrid materials via sol-gel technique. J. Therm. Anal. Calorim. 2017, 130, 535–540. [Google Scholar] [CrossRef]
  50. Naviglio, S.; Matteucci, C.; Matoskova, B.; Nagase, T.; Nomura, N.; Di Fiore, P.P.; Draetta, G.F. Ubpy: A growth-regulated human ubiquitin isopeptidase. EMBO J. 1998, 17, 3241–3250. [Google Scholar] [CrossRef] [PubMed]
  51. Moraleva, A.; Magoulas, C.; Polzikov, M.; Hacot, S.; Mertani, H.C.; Diaz, J.J.; Zatsepina, O. Involvement of the specific nucleolar protein surf6 in regulation of proliferation and ribosome biogenesis in mouse nih/3t3 fibroblasts. Cell Cycle 2017, 16, 1979–1991. [Google Scholar] [CrossRef] [PubMed]
  52. Ogawa, Y.; Yamamoto, M.; Okada, H.; Yashiki, T.; Shimamoto, T. A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly (lactic/glycolic) acid. Chem. Pharm. Bull. 1988, 36, 1095–1103. [Google Scholar] [CrossRef] [PubMed]
  53. Tokiwa, Y.; Suzuki, T. Hydrolysis of polyesters by lipases. Nature 1977, 270, 76–78. [Google Scholar] [CrossRef] [PubMed]
  54. O’Brien, V.; Campo, M.S. Bpv-4 E8 transforms NIH 3T3 cells, up-regulates cyclin a and cyclin a-associated kinase activity and de-regulates expression of the cdk inhibitor p27 Kip1. Oncogene 1998, 17, 293–301. [Google Scholar] [CrossRef] [PubMed]
  55. Guardavaccaro, D.; Pagano, M. Stabilizers and destabilizers controlling cell cycle oscillators. Mol. Cell 2006, 22, 1–4. [Google Scholar] [CrossRef] [PubMed]
  56. Sapio, L.; Sorvillo, L.; Illiano, M.; Chiosi, E.; Spina, A.; Naviglio, S. Inorganic phosphate prevents Erk1/2 and Stat3 activation and improves sensitivity to doxorubicin of mda-mb-231 breast cancer cells. Molecules 2015, 20, 15910–15928. [Google Scholar] [CrossRef] [PubMed]
Materials 10 01186 g001 550
Figure 1. Typical phase-contrast images of NIH 3T3 cells treated with and without PCL-free ZrO2 material and poly(e-caprolactone) (PCL)/ZrO2 hybrids with different percentages of PCL (6 wt %, 12 wt %, 24 wt %, 50 wt %) for 48 h.
Figure 1. Typical phase-contrast images of NIH 3T3 cells treated with and without PCL-free ZrO2 material and poly(e-caprolactone) (PCL)/ZrO2 hybrids with different percentages of PCL (6 wt %, 12 wt %, 24 wt %, 50 wt %) for 48 h.
Materials 10 01186 g001
Materials 10 01186 g002 550
Figure 2. Trypan Blue Exclusion Dye test. NIH-3T3 cells were cultured in 10% serum containing medium in the absence (control, CTR) or presence of PCL-free ZrO2 and PCL/ZrO2 hybrid materials with different percentages (6 wt %, 12 wt %, 24 wt %, 50 wt %) for 24 and 48 h. Then, the cell number was recorded as stated in Materials and Methods. Data represent the average of three independent experiments. The means and S.D. are shown. *, p < 0.05 vs. control cells.
Figure 2. Trypan Blue Exclusion Dye test. NIH-3T3 cells were cultured in 10% serum containing medium in the absence (control, CTR) or presence of PCL-free ZrO2 and PCL/ZrO2 hybrid materials with different percentages (6 wt %, 12 wt %, 24 wt %, 50 wt %) for 24 and 48 h. Then, the cell number was recorded as stated in Materials and Methods. Data represent the average of three independent experiments. The means and S.D. are shown. *, p < 0.05 vs. control cells.
Materials 10 01186 g002
Materials 10 01186 g003 550
Figure 3. Effects of PCL-free ZrO2 material, PCL/ZrO2 hybrid materials with different percentages (6 wt %, 12 wt %, 24 wt %, 50 wt %) of PCL on cell proliferation. NIH-3T3 cells were cultured in 10% serum containing medium in the absence (control, CTR) or presence of the indicated substances for 24 and 48 h. Then, the cell number was recorded (A); and cell viability was measured by MTT assay (B). Data represent the average of three independent experiments. The means and S.D. are shown. * p < 0.05 vs. PCL-free ZrO2 treated-cells.
Figure 3. Effects of PCL-free ZrO2 material, PCL/ZrO2 hybrid materials with different percentages (6 wt %, 12 wt %, 24 wt %, 50 wt %) of PCL on cell proliferation. NIH-3T3 cells were cultured in 10% serum containing medium in the absence (control, CTR) or presence of the indicated substances for 24 and 48 h. Then, the cell number was recorded (A); and cell viability was measured by MTT assay (B). Data represent the average of three independent experiments. The means and S.D. are shown. * p < 0.05 vs. PCL-free ZrO2 treated-cells.
Materials 10 01186 g003
Materials 10 01186 g004 550
Figure 4. Effects of pure ZrO2, PCL/ZrO2 hybrid materials with different PCL percentages (6 wt %, 12 wt %, 24 wt %, 50 wt %) in low serum (1%) containing medium on cell proliferation. NIH-3T3 cells were cultured in low serum (1%) containing medium in the absence (control) or presence of the indicated substances for 24 and 48 h. Then, the cell number was recorded. Data represent the average of three independent experiments. The means and S.D. are shown. * p < 0.05 vs. PCL-free ZrO2 treated-cells.
Figure 4. Effects of pure ZrO2, PCL/ZrO2 hybrid materials with different PCL percentages (6 wt %, 12 wt %, 24 wt %, 50 wt %) in low serum (1%) containing medium on cell proliferation. NIH-3T3 cells were cultured in low serum (1%) containing medium in the absence (control) or presence of the indicated substances for 24 and 48 h. Then, the cell number was recorded. Data represent the average of three independent experiments. The means and S.D. are shown. * p < 0.05 vs. PCL-free ZrO2 treated-cells.
Materials 10 01186 g004
Materials 10 01186 g005 550
Figure 5. Effects of ZrO2 material alone and PCL/ZrO2 hybrid materials with different PCL percentages (6 wt %, 12 wt %, 24 wt %, 50 wt %) on the distribution of NIH-3T3 cells in cell cycle phases and on the levels of some relevant cell cycle regulating proteins. NIH-3T3 cells were cultured in the absence (control, CTR) or presence of the indicated substances for 48 h. (A) FACS analysis of propidium iodide stained cells. Profiles and quantitative data indicating the percentage of G0/G1, S, and G2/M cells from a typical representative experiment; (B) 30 μg of cell extracts were subjected to SDS-PAGE and blotted with antibodies against the indicated proteins (α-tubulin was used as a standard for the equal loading of protein in the lanes). The image is representative of two immunoblotting analyseis from two different cellular preparations with similar results; (C) Graphs showing the densitometric intensity of Cyc A and p27/tubulin bands ratio. The intensities of signals were expressed as arbitrary units. * p < 0.05 vs. control untreated cells.
Figure 5. Effects of ZrO2 material alone and PCL/ZrO2 hybrid materials with different PCL percentages (6 wt %, 12 wt %, 24 wt %, 50 wt %) on the distribution of NIH-3T3 cells in cell cycle phases and on the levels of some relevant cell cycle regulating proteins. NIH-3T3 cells were cultured in the absence (control, CTR) or presence of the indicated substances for 48 h. (A) FACS analysis of propidium iodide stained cells. Profiles and quantitative data indicating the percentage of G0/G1, S, and G2/M cells from a typical representative experiment; (B) 30 μg of cell extracts were subjected to SDS-PAGE and blotted with antibodies against the indicated proteins (α-tubulin was used as a standard for the equal loading of protein in the lanes). The image is representative of two immunoblotting analyseis from two different cellular preparations with similar results; (C) Graphs showing the densitometric intensity of Cyc A and p27/tubulin bands ratio. The intensities of signals were expressed as arbitrary units. * p < 0.05 vs. control untreated cells.
Materials 10 01186 g005
Materials 10 01186 g006 550
Figure 6. Flow chart of hybrids synthesis by the sol-gel method and the molar ratios between the reagents achieved in the sol.
Figure 6. Flow chart of hybrids synthesis by the sol-gel method and the molar ratios between the reagents achieved in the sol.
Materials 10 01186 g006
Table
Table 1. Effects of pure ZrO2 material, PCL/ZrO2 hybrid materials with different percentages (6 wt %, 12 wt %, 24 wt %, 50 wt %) of PCL, and doxorubicin on the release of AST, ALT, LDH intracellular enzymatic activities. NIH-3T3 cells were cultured in the absence (control) or presence of the indicated substances for 72 h. Then, the medium from cultured cells plates and “blank” plates was collected and tested for the indicated parameters. Values are means ± S.D. of triplicate samples of a typical experiment. *, p < 0.05 hybrids vs. PCL-free ZrO2 treated-cells and Doxo vs. control.
Table 1. Effects of pure ZrO2 material, PCL/ZrO2 hybrid materials with different percentages (6 wt %, 12 wt %, 24 wt %, 50 wt %) of PCL, and doxorubicin on the release of AST, ALT, LDH intracellular enzymatic activities. NIH-3T3 cells were cultured in the absence (control) or presence of the indicated substances for 72 h. Then, the medium from cultured cells plates and “blank” plates was collected and tested for the indicated parameters. Values are means ± S.D. of triplicate samples of a typical experiment. *, p < 0.05 hybrids vs. PCL-free ZrO2 treated-cells and Doxo vs. control.
Sample LabelsTotal Proteins g/dLAST U/LALT U/LLDH U/L
Blank1.0 ± 0.053 ± 0.16 ± 0.254 ± 1
Control1.1 ± 0.045 ± 0.16 ± 0.158 ± 2
ZrO21.1 ± 0.036 ± 0.36 ± 0.261 ± 3
6 wt % PCL1.0 ± 0.035 ± 0.26 ± 0.164 ± 2 *
12 wt % PCL1.1 ± 0.025 ± 0.36 ± 0.363 ± 3
24 wt % PCL1.1 ± 0.056 ± 0.26 ± 0.462 ± 3
50 wt % PCL1.0 ± 0.025 ± 0.16 ± 0.164 ± 2 *
DOXO1.1 ± 0.0523 ± 1 *6 ± 0.2130 ± 5 *

Share and Cite

MDPI and ACS Style

Catauro, M.; Tranquillo, E.; Illiano, M.; Sapio, L.; Spina, A.; Naviglio, S. The Influence of the Polymer Amount on the Biological Properties of PCL/ZrO2 Hybrid Materials Synthesized via Sol-Gel Technique. Materials 2017, 10, 1186. https://doi.org/10.3390/ma10101186

AMA Style

Catauro M, Tranquillo E, Illiano M, Sapio L, Spina A, Naviglio S. The Influence of the Polymer Amount on the Biological Properties of PCL/ZrO2 Hybrid Materials Synthesized via Sol-Gel Technique. Materials. 2017; 10(10):1186. https://doi.org/10.3390/ma10101186

Chicago/Turabian Style

Catauro, Michelina, Elisabetta Tranquillo, Michela Illiano, Luigi Sapio, Annamaria Spina, and Silvio Naviglio. 2017. "The Influence of the Polymer Amount on the Biological Properties of PCL/ZrO2 Hybrid Materials Synthesized via Sol-Gel Technique" Materials 10, no. 10: 1186. https://doi.org/10.3390/ma10101186

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop